drugset / Trial / NCT03774745
Blocking Mifepristone Action With Progesterone
Phase 1/2
Terminated
12 enrolled
University of California, Davis
Society of Family Planning · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Double-blind randomized trial to evaluate the potential impact of progesterone treatment on early pregnancies exposed to mifepristone.
Timeline
- Start
- 2019-02-11
- Primary completion
- 2019-07-29
- Completion
- 2019-08-15
Outcome
Results reported · no primary-endpoint met/missed verdict (typical of a dose-finding / safety study)
Stopped: “Safety”
paper We could not estimate the efficacy of progesterone for mifepristone antagonization due to safety concerns PMID 31809439 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Progesterone | Other / unclassified | 400 mg | Oral |
| Background | Mifepristone | Small molecule | 200 mg | Oral |
Indications
No indication recorded.